IBD...three letters that, if you’re diagnosed with having, can ruin your life. About 3 million Americans are living with the pain of inflammatory bowel disease. IBD ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists are generally familiar with complicated case patients who require management across specialties.

Maintaining higher trough levels of infliximab (Remicade) of >7 μg/mL provided better control of inflammatory bowel disease (IBD) in hard-to-treat patients with no increase in infection risk, ...

New IBD research shows that, even during clinical remission, people living with Crohn's disease continue to experience greater work impairment than the general population The new campaign aims to ...

Michelle Pickens’ symptoms escalated in college. At the time, she was throwing up at least once a day, and experiencing frequent nausea, abdominal pain, diarrhea, and constipation. Juggling classes ...

SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed. Among ...

Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.

Although some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel disease (IBD) hasn’t seemed to make that list yet, even though the condition ...

Inflammatory bowel disease (IBD) is an umbrella term for several conditions that affect the intestinal tract. IBD happens when the immune system mistakenly attacks healthy tissue in the intestines.

Crohn's disease (CD) and ulcerative colitis (UC), the two main forms of IBD, affect around 10 million people worldwide, and the number of patients is increasing in Asia[1],[2],[3]. Typically beginning ...